Cargando…

Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours

Prompted by the observation of ischaemia development during the treatment of tumours by photodynamic therapy (PDT) that is typically followed by a restoration of tumour blood flow and by the indications of secondary superoxide generation after PDT, we aimed in this study to obtain evidence of the in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korbelik, M, Sun, J, Zeng, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376337/ https://www.ncbi.nlm.nih.gov/pubmed/12618887 http://dx.doi.org/10.1038/sj.bjc.6600792

Ejemplares similares

Photodynamic therapy-generated vaccines: relevance of tumour cell death expression
por: Korbelik, M, et al.
Publicado: (2007)

Potentiation of photodynamic therapy of cancer by complement: the effect of γ-inulin
por: Korbelik, M, et al.
Publicado: (2007)

The role of reperfusion injury in photodynamic therapy with 5-aminolaevulinic acid – a study on normal rat colon
por: Curnow, A, et al.
Publicado: (2002)

Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment
por: Kelleher, D K, et al.
Publicado: (2003)

Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours
por: Kelleher, D K, et al.
Publicado: (2003)

Selectivity of the photosensitiser Tookad® for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model
por: Borle, F, et al.
Publicado: (2003)

Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas
por: Separovic, D, et al.
Publicado: (2009)

Photodynamic therapy effect of m-THPC (Foscan®) in vivo: correlation with pharmacokinetics
por: Jones, H J, et al.
Publicado: (2003)

Role of cytokines in photodynamic therapy-induced local and systemic inflammation
por: Gollnick, S O, et al.
Publicado: (2003)

Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation
por: Wyld, L, et al.
Publicado: (2002)

Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen
por: Reginato, E, et al.
Publicado: (2013)

Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies
por: Perotti, C, et al.
Publicado: (2004)

Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy
por: Chiu, S-M, et al.
Publicado: (2003)

Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma
por: Ickowicz Schwartz, D, et al.
Publicado: (2004)

Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy
por: Golding, J P, et al.
Publicado: (2013)

Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo
por: Babilas, P, et al.
Publicado: (2003)

Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice
por: Gil, M, et al.
Publicado: (2011)

Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy
por: Hamblin, M R, et al.
Publicado: (2003)

Foscan® uptake and tissue distribution in relation to photodynamic efficacy
por: Cramers, P, et al.
Publicado: (2003)

Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model
por: Mukherjee, P, et al.
Publicado: (2002)

Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver
por: Woodhams, J H, et al.
Publicado: (2004)

Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study
por: Lüdicke, F, et al.
Publicado: (2003)

Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.
por: Krosl, G., et al.
Publicado: (1995)

Depth distributions of bacteria for the Pseudomonas aeruginosa-infected burn wounds treated by methylene blue-mediated photodynamic therapy in rats: effects of additives to photosensitizer
por: Sarker, Roma R., et al.
Publicado: (2022)

A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy
por: Castano, A P, et al.
Publicado: (2006)

Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma
por: Otake, M, et al.
Publicado: (2003)

Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy
por: Korbelik, M, et al.
Publicado: (2000)

The role of ischaemia-reperfusion injury and liver regeneration in hepatic tumour recurrence
por: Maspero, Marianna, et al.
Publicado: (2023)

Irradiance uniformity optimization for a photodynamic therapy treatment device with 3D scanner
por: Wang, Xu, et al.
Publicado: (2021)

Periodate-treated, non-anticoagulant heparin-carrying polystyrene (NAC-HCPS) affects angiogenesis and inhibits subcutaneous induced tumour growth and metastasis to the lung
por: Ono, K, et al.
Publicado: (2002)

The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy.
por: Korbelik, M., et al.
Publicado: (1998)

Complement in ischaemia–reperfusion injury and transplantation
por: Howard, Mark C., et al.
Publicado: (2021)

Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury
por: Baidya, Raji, et al.
Publicado: (2020)

Secreted and tumour targeted human carboxylesterase for activation of irinotecan
por: Oosterhoff, D, et al.
Publicado: (2002)

Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells
por: Ortel, B, et al.
Publicado: (2002)

Invasion and MMP expression profile in desmoid tumours
por: Denys, H, et al.
Publicado: (2004)

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)
por: Duverger, V, et al.
Publicado: (2004)

Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid
por: Niedre, M J, et al.
Publicado: (2005)

Mreg Activity in Tumor Response to Photodynamic Therapy and Photodynamic Therapy-Generated Cancer Vaccines
por: Korbelik, Mladen, et al.
Publicado: (2016)

Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth
por: Park, I-S, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_5ha40l2o61nvhh03cl33j1l9ve